New TB cocktail aims to shorten treatment
Disease control
Not yet recruiting
This study tests a new combination of three drugs—sorfequiline, pretomanid, and linezolid—in 100 adults with newly diagnosed, drug-sensitive tuberculosis. Participants take the pills daily for 17 weeks. The goal is to see if the combo is safe and can clear the infection faster th…
Phase: PHASE2 • Sponsor: Global Alliance for TB Drug Development • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC